(Q43503861)

English

Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study

scientific article published on 7 May 2012

Statements

Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study (English)
Céline Bourgier
Jean-Marc Ferrero
Sophie Abadie-Lacourtoisie
Jean-Christophe Eymard
Dominique Spaëth
Djelila Allouache
Claude El Kouri
Eric Pujade-Lauraine

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit